Skip to content Skip to sidebar Skip to footer

Newsletter

Technology

Metallium Soars 10% as Rice University Collaboration Confirms U.S. Rare Earth Refining Potential

Following a strong peer-reviewed study published by Rice University, Metallium (ASX: MTM) has received a major credibility boost for its patented Flash Joule Heating (FJH) technology. The research confirmed the effectiveness of the process and its potential to advance U.S.-based rare earth refining capabilities, a key milestone given ongoing geopolitical tensions between China and the…

ByCharlie YouldenOctober 15, 2025

Telix Pharmaceuticals (ASX: TLX) Stages a Comeback as FY25 Update Signals Renewed Momentum

Telix Pharmaceuticals (ASX: TLX) has been one of Australia’s most talked-about biotech stories ... a company that once soared on excitement, stumbled through FDA delays and accounting scrutiny, and is now showing early signs of revival. After a turbulent stretch that tested investor patience, the company has released its FY25 (ending December) guidance, and the…

ByCharlie YouldenOctober 15, 2025

Solidion (NASDAQ: STI) Soars 293% on UPS AI Data Centre Battery Announcement

Solidion Technology (NASDAQ: STI) stunned the market this week, soaring 293 percent to USD $23 after unveiling a new proprietary semi-solid-state battery system designed for AI data centres. The breakthrough lies in its ability to act as an uninterruptible power supply, keeping servers online during outages while offering exceptional performance metrics. The system boasts an…

ByCharlie YouldenOctober 14, 2025

Metallium Ltd (ASX:MTM) Texas Facility Scale-Up and 8,000 Tpa REE Expansion

Few investors expected Metallium (ASX: MTM) to turn heads last week, yet its latest announcement from Texas highlighted some interesting notes that investors should follow closely. The company revealed a major expansion at its Gator Point Technology Campus, lifting e-waste processing capacity fivefold to 8,000 tonnes per year. That translates to roughly 1,600 tonnes of…

ByCharlie YouldenOctober 14, 2025

Rejecting a takeover offer: Here are 6 ASX stocks that did and how it ended for them

Rejecting a takeover offer is a bold step for an ASX company to take. It is turning down sweet quick cash for its shareholders and management. The argument most commonly made to reject them is that any offers are opportunistic and do not appropriately value the company - indeed, those very words are commonly used. The board…

ByNick SundichOctober 14, 2025

1414 Degrees (ASX: 14D) Secures Silicon Battery Technology from George Washington University

1414 Degrees Taps U.S. Innovation to Advance Next-Generation Battery Technology It is not every day that a small Australian energy company steps into the global battery race. Yet today, 1414 Degrees (ASX: 14D) announced an exclusive licence agreement with George Washington University to commercialise a breakthrough silicon nanoparticle technology designed for lithium-ion battery anodes. The opportunity…

ByCharlie YouldenOctober 9, 2025

Cyclopharm (ASX:CYC): FDA approved for 2 years now, but a lawsuit from 4DX is the latest headache and cause for investor scepticism

Cyclopharm (ASX:CYC) is a rare species - an ASX stock that is approved in the US market. However, its share price has gone in the opposite direction. Cyclopharm has not had as fast an uplift as other companies have had and still makes most of its sales from other jurisdictions. A lawsuit from 4D Medical…

ByNick SundichOctober 8, 2025

Activist investors: Here’s what you need to know about them and 4 famous Australian activists to watch out for

Hear the term 'Activist investors' and you might think of GetUp, the progressive activist group that forced Woolworths to hold an EGM in 2014 in an attempt to limit the maximum bets on poker machines to $1. Or perhaps even of ESG-focused fundies like Australian Ethical (ASX:AEF). The reality is a lot more complicated and…

ByNick SundichOctober 8, 2025

Acusensus (ASX: ACE) Surges 18% on Major USD 22 Million U.S. Contract Win

The AI-Driven Road Safety Company Winning Government Contracts Worldwide Acusensus (ASX: ACE) grabbed investors’ attention today after its share price surged 18 percent on news of a major contract win in the United States. The company secured a deal worth an estimated USD 22 million to deliver automated work zone speed control systems across Connecticut, marking…

ByCharlie YouldenOctober 7, 2025

Weebit Nano’s 185% Rally, Onsemi Breakthrough Brings ReRAM Closer to Reality

Weebit Nano’s onsemi Milestone Strengthens Commercial Outlook After 185% Share Price Surge over the past 6 months Weebit Nano (ASX:WBT) has achieved a significant milestone in its journey toward commercialising its next-generation memory technology, Resistive Random Access Memory (ReRAM). The company has successfully completed the “tape-out” phase — the point where chip designs are finalised…

ByCharlie YouldenOctober 7, 2025

the Kick-ass Multipurpose WordPress Theme

Technology

Metallium Soars 10% as Rice University Collaboration Confirms U.S. Rare Earth Refining Potential

Telix Pharmaceuticals (ASX: TLX) Stages a Comeback as FY25 Update Signals Renewed Momentum

Solidion (NASDAQ: STI) Soars 293% on UPS AI Data Centre Battery Announcement

Metallium Ltd (ASX:MTM) Texas Facility Scale-Up and 8,000 Tpa REE Expansion

Rejecting a takeover offer: Here are 6 ASX stocks that did and how it ended for them

1414 Degrees (ASX: 14D) Secures Silicon Battery Technology from George Washington University

Cyclopharm (ASX:CYC): FDA approved for 2 years now, but a lawsuit from 4DX is the latest headache and cause for investor scepticism

Activist investors: Here’s what you need to know about them and 4 famous Australian activists to watch out for

Acusensus (ASX: ACE) Surges 18% on Major USD 22 Million U.S. Contract Win

Weebit Nano’s 185% Rally, Onsemi Breakthrough Brings ReRAM Closer to Reality

Stocks in Spotlight

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Technology

Stocks in Spotlight

Add Your Heading Text Here